Finally, we have analyzed EIF5 and EIF5B expression in gliomas and found that EIF5 is downregulated in astrocytomas and in GBM, only for the mesenchymal and proneural subtypes (Table 1). This evidence concerns the gene EIF5B and central nervous system cancer.